Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Well, the first step is diagnosis. We have ...

dementia Additional studies are needed to determine whether anemia itself is a risk factor for dementia in the CKD population. Anemia in patients with chronic kidney disease (CKD) portends an ...

Authors of a recent review explored the complex relationship between CKD, COVID-19, and anemia and offered practice points based on clinical experience. Patients with chronic kidney disease (CKD) ...

Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be a better adjunct treatment to reduce anemia risk than glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for patients with type 2 diabetes ...

The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment ...